Suchergebnisse - "Knapper, Steven"

PubPharm (67)

21

Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia

enthalten in: Blood advances | 2019

von Milne, P. | Wilhelm-Benartzi, C. | Grunwald, M. | +15

22

A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia

enthalten in: Molecular psychiatry | 2019

von Legge, S. | Pardiñas, A. | Helthuis, M. | +9

23

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis : A British Society for Haematology Guideline

enthalten in: British journal of haematology | 2019

von McMullin, M. | Mead, A. | Ali, S. | +12

24

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide

enthalten in: Blood | 2017

von Harrison, C. | Mead, A. | Panchal, A. | +18

CommentIn: Blood. 2017 Oct 26;130(17):1873-1874. - PMID 29074591

25

Telomere length is an independent prognostic marker in MDS but not in de novo AML

enthalten in: British journal of haematology | 2017

von Williams, J. | Heppel, N. | Britt-Compton, B. | +10

26

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML

enthalten in: Blood | 2017

von Knapper, S. | Russell, N. | Gilkes, A. | +10

CommentIn: Blood. 2017 Mar 2;129(9):1061-1062. - PMID 28254820

27

Guideline for the investigation and management of eosinophilia

enthalten in: British journal of haematology | 2017

von Butt, N. | Lambert, J. | Ali, S. | +11

CommentIn: Br J Haematol. 2020 Mar;188(5):e76-e79. - PMID 31854104

28

Guideline for the investigation and management of eosinophilia

enthalten in: British journal of haematology | 2017

von Butt, N. | Lambert, J. | Ali, S. | +10

29

Guideline for the investigation and management of eosinophilia

enthalten in: British journal of haematology | 2017

von Butt, N. | Lambert, J. | Ali, S. | +10

30

Telomere length is an independent prognostic marker in MDS but not in de novo AML

enthalten in: British journal of haematology | 2017

von Williams, J. | Heppel, N. | Britt‐Compton, B. | +10